Skip to content

Michael Cox

My feedback

1 result found

  1. 11 votes
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    Michael Cox supported this idea  · 
    An error occurred while saving the comment
    Michael Cox commented  · 

    Further details are now added to the forum for viewpoints.

    Clinical use:
    To minimize risk to recipients, a blood sample of a deceased donor of tissues or cells is collected and tested for communicable disease. It is recognized the volume of blood, colloids and crystalloids infused prior to death may affect these test results and an algorithm is used to determine the acceptability of a blood sample for infectious marker testing.

    PRELIMINARY QUESTIONS FOR DETERMINING IF A DONOR SPECIMEN IS ADEQUATE FOR INFECTIOUS DISEASE TESTING.

    Question 1
    Has the donor had a transfusion or infusion?
    • If the answer is no, then test the blood specimen
    • If the answer is yes, then ask question 2

    Question 2
    Is the donor more than twelve years old?
    • If the answer is no, then ask question 2a
    • If the answer is yes, then ask question 3

    Question 2a
    Is there a recent pre-transfusion/infusion blood specimen available for the donor who is twelve years of age or younger?
    • If the answer is no, then apply the algorithm worksheet
    • If the answer is yes, then test the pre-transfusion/infusion blood specimen that is available

    Question 3
    Is there a recent pre-transfusion/infusion blood specimen available for the donor who is more than twelve years of age?
    • If the answer is yes, then test the pre-transfusion/infusion blood specimen
    • If the answer is no, then ask Question 4

    Question 4
    Has blood loss occurred?
    • If the answer is no, then test the blood specimen
    • If the answer is yes, then ask Question 5

    Question 5
    Are any of the following conditions exceeded?
    • 2000 mL of blood or colloid given to the donor within the past 48 hours;
    • 2000 mL of crystalloids within the last hour; or
    • 2000 mL total of any combination of blood and colloid within past 48 hours, and crystalloid in the past hour
    • If the answer is no, then test the blood specimen
    • If the answer is yes, then apply the algorithm worksheet

    Algorithm (Worksheet).

    Donor ID: _________________
    Date of sampling: ________________
    Time of sampling (00.00): ________________
    Donor Weight (kg): _________________

    Blood Volume (BV) = donor’s weight (kg) ÷ 0.015 = ____ ml
    or (BV) = donor’s weight (kg) x 70 mL/kg = ____ mL

    Plasma Volume (PV) = donor’s weight (kg) ÷ 0.025 = ____ mL
    or (PV) = donor’s weight (kg) x 40 mL/kg = ____ mL

    A. Total Volume of Blood transfused/48 hours *
    A1. Volume of RBCs transfused/48 hours ____ mL
    A2. Volume of Whole blood transfused/48 hours ____ mL
    Total volume (A = A1 + A2) ____ mL
    (Enter “zero” if not transfused).

    B. Total Volume of Colloid infused/48 hours *
    B1. Volume of Dextran ____ mL
    B2. Volume of plasma ____ mL
    B3. Volume of platelets ____ mL
    B4. Volume of albumin ____ mL
    B5. Volume of hetastarch ____mL
    B6. Volume of other ____ mL
    Total volume (B = B1 to B6) ____ mL
    (Enter “zero” if not infused).

    C. Total Volume of Crystalloid Infused/1 hour *
    C1. Volume of saline ____ mL
    C2. Volume of Dextrose in water ____ mL
    C3. Volume of Ringer’s lactate ____ mL
    C4. Volume of other ____ mL
    Total volume (C = C1 to C4) ____ mL
    (Enter “zero” if not infused).

    Determination of Sample Acceptability for Infectious Disease Tests:
    Calculate both D and E below.
    D. Is the sum of B + C greater than PV? Yes or No.
    E. Is the sum of A + B + C greater than BV? Yes or No.

    The post-transfusion/infusion sample is acceptable for testing where the answer to both D and E are “No”,
    The post-transfusion/infusion sample is not acceptable if the answer to either D or E is “Yes”,
    (In the latter case use a pre-transfusion/infusion sample or reject the potential donor of human tissues/cells).
    * before death or sample collection, whichever comes first.

    References
    1. Directive 2006/17/EC of 8th February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for donation, procurement and testing of human tissues and cells. Official Journal of the European Union, L38/40 09/02/2006.
    2. Guidance for Industry: Eligibility determination for donors of human cells, tissues and cellular and tissue based products (HCT/Ps), FDA, Center for Biologics Evaluation and Research, August 2007.
    http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm091345.pdf
    3. Chopek, M.M., Protein and Biochemical Changes During Plasma Exchange. Therapeutic Hemapheresis: A Technical Workshop Presented by the Committee on Technical Workshops, American Association of Blood Banks 1980; 1980:13-52.
    4. Hemodilution-an overview of current canadian practices, Cell and Tissue Banking, 2: 41-44.2001.

    Michael Cox shared this idea  · 

Feedback and Knowledge Base